Skip to main content
Porton Pharma Solutions Ltd. logo

Porton Pharma Solutions Ltd. — Investor Relations & Filings

Ticker · 300363 ISIN · CNE100001S57 LEI · 300300IQTJFHA0YRXE68 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,163 across all filing types
Latest filing 2024-08-19 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300363

About Porton Pharma Solutions Ltd.

https://www.porton.cn

Porton Pharma Solutions Ltd. is a global contract development and manufacturing organization (CDMO) providing end-to-end solutions for the pharmaceutical and biotechnology sectors. The company specializes in the development and manufacturing of small molecule APIs, intermediates, and drug products, while expanding its capabilities into biologics and cell and gene therapies. Its service portfolio encompasses process research and development, analytical services, pilot-scale production, and large-scale commercial manufacturing. Porton operates a network of R&D centers and manufacturing facilities designed to meet international regulatory standards, including those of the FDA and EMA. By leveraging an integrated technology platform, the company supports clients throughout the entire drug lifecycle, from preclinical development to commercialization, focusing on operational excellence and supply chain security.

Recent filings

Filing Released Lang Actions
关于全资子公司完成注销登记的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement regarding the completion of the deregistration (注销登记) of a wholly-owned subsidiary by the company. It states the impact on consolidated financial statements but does not contain any financial data or detailed reports. The document is brief (424 characters) and serves as a formal notification of a corporate structural change rather than a financial report or detailed management information. This fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-08-19 Chinese
关于实际控制人部分股份质押及解除质押的公告
Major Shareholding Notification Classification · 95% confidence The document is a public announcement regarding the pledge and release of shares by the company's actual controller and related parties. It details the number of shares pledged, released, and cumulative pledges, along with the purpose and impact of these pledges. There is no financial statement, earnings data, or management discussion. The document is a regulatory announcement about share pledging activities by major shareholders, which fits the category of Major Shareholding Notification (MRQ). The document length is 2630 characters, which is typical for such announcements. Therefore, the appropriate classification is MRQ.
2024-08-12 Chinese
关于公司高级管理人员辞职的公告
Board/Management Information Classification · 100% confidence The document is a formal announcement regarding the resignation of a senior management member, specifically the vice general manager, including details about the resignation effective date, legal references, and acknowledgments. It does not contain financial data, audit information, or report content. It clearly fits the category of announcements about changes in senior management or board members.
2024-08-02 Chinese
关于公司限制性股票回购注销完成的公告
Transaction in Own Shares Classification · 100% confidence The document is an official announcement from Chongqing Boteng Pharmaceutical Technology Co., Ltd. regarding the completion of the repurchase and cancellation of restricted shares. It details the number of shares repurchased, the price adjustments, approvals from various board and supervisory meetings, and the completion of the repurchase process including verification by an accounting firm. The document includes specific dates, share quantities, and financial figures related to the repurchase and cancellation of shares. This type of document is a formal announcement about a transaction involving the company's own shares, specifically a share repurchase and cancellation of restricted stock. It is not a full financial report, earnings release, or management discussion, but rather a capital change event. Therefore, the appropriate classification is "Transaction in Own Shares (POS)" which covers share repurchase/issuance announcements.
2024-07-29 Chinese
关于收购Porton Europe. NV少数股权的进展公告
M&A Activity Classification · 95% confidence The document is an announcement regarding the progress of an acquisition, specifically the completion of the acquisition of minority shares in Porton Europe. NV, making it a wholly owned subsidiary. It references a prior board meeting resolution and provides an update on the transaction status. This fits the category of M&A Activity announcements, which cover merger proposals or takeover bids and related progress updates. The document is short and focused on the acquisition progress, not a full merger filing or proxy statement, so it is best classified under M&A Activity (TAR).
2024-07-23 Chinese
关于完成工商变更登记的公告
Share Issue/Capital Change Classification · 95% confidence The document is a company announcement regarding the completion of business registration changes, specifically about the reduction of registered capital due to share repurchases and amendments to the company's articles of association. It references prior announcements and resolutions but does not contain financial statements or detailed financial data. The document is short (1277 characters) and serves as a formal notice of completed registration changes rather than a full report or detailed financial disclosure. Therefore, it fits best under the category of Share Issue/Capital Change (SHA), which covers announcements regarding capital changes such as share repurchases and registered capital adjustments.
2024-07-23 Chinese

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.